Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cohbar Inc (NQ: CWBR )

1.400 USD -0.030 (-2.10%)
Official Closing Price Updated: 5:00 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 327,634
Open 1.430
Bid (Size) 1.400 (7)
Ask (Size) 1.450 (30)
Prev. Close 1.430
Today's Range 1.390 - 1.440
52wk Range 0.8500 - 4.250
Shares Outstanding 42,363,670
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
CohBar Announces Preclinical Collaboration with NIAID to Evaluate Potential of CB5064 Analogs for Treatment of COVID-19 ARDS
From GlobeNewswire News Releases
CohBar Confirms Efficacy of Novel Apelin Agonists in Acute Respiratory Distress Syndrome (ARDS) Model
From GlobeNewswire News Releases

Performance

YTD
+6.06%
+6.06%
1 Month
+8.53%
+8.53%
3 Month
+43.06%
+43.06%
6 Month
-17.65%
-17.65%
1 Year
-37.47%
-37.47%

More News

Read More
MatriSys Bioscience names Dr. Phillipe Calais as its New Chief Executive Officer and Member of its Board of Directors
Tags technology banking/finance/investment h:worldnews
From EIN Presswire
CohBar to Present at the Piper Sandler 32nd Annual Healthcare Conference
From GlobeNewswire News Releases
CohBar Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
CohBar to Announce 2020 Third Quarter Financial Results and Provide Business Update on November 16, 2020
From GlobeNewswire News Releases
CohBar to Host Key Opinion Leader Meeting on Antifibrotic Peptides for the Potential Treatment of Idiopathic Pulmonary Fibrosis
From GlobeNewswire News Releases
CohBar to Participate at ROTH Capital COVID-19 Therapeutics in Development Event
From GlobeNewswire News Releases
CohBar Antifibrotic Peptide in Combination with Nintedanib Shows Enhanced Effects in an Idiopathic Pulmonary Fibrosis Model
From GlobeNewswire News Releases
CohBar to Present at the BIO-Europe Conference
From GlobeNewswire News Releases
CohBar’s CEO to Participate on the Emerging Companies Panel at the Targeting Metabesity Conference
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.